Leap 1009
Immuno‑oncology / Solid tumors
PreclinicalActive
Key Facts
About Ability Biotherapeutics
AI‑driven platform developer creates conditional, multispecific antibodies for cancer and autoimmune disease.
View full company profileTherapeutic Areas
Other Immuno‑oncology / Solid tumors Drugs
| Drug | Company | Phase |
|---|---|---|
| Leap 1030 | Ability Biotherapeutics | Preclinical |